Riboksin. for use in ampoules Instructions. Composition, therapeutic properties

One of modern medicine, having a positive effect on the metabolism and energy supply of the organism tissue is Riboxin. This metabolic drug prior to ATP.

It recommended as an anabolic, antiarrhythmic, anti-hypoxic and vasodilatig drug.

It is intended to stimulate the enzymatic cycle Krebesa and nucleotide synthesis. Directly participates in glucose metabolism.

It is recommended to improve the energy balance of the heart muscle (Myocardium) adjusts operation of coronary blood flow, hypoxia activates exchanges in cases of absence of ATP.

According to the instructions for use in drug ampules assigned for administration droplets, tablets - for oral administration.

Riboksin impact on various organs

The drug is released in 2 forms (tablets and solution). It is intended to stimulate the metabolic processes at the cellular level.

After entering into the plasma drug penetrates quickly to sensitive tissues. Agent refers to a group of nucleoside (substances contained in tissues different cells).

After penetration into the cells of the charge with the necessary energy to activate all kinds of materials for metabolic processes.

As a result - the cells are animated, becoming not reachable for the destruction of the negative impacts.

The heart muscle is called "myocardium", she is particularly sensitive to the drug. Due to its non-stop operation of its cells require uninterrupted delivery of nutrients and oxygen.

In the absence of an amount appears in the right body painful symptomatology, then begin to die cardiac myocardial cells. Such a flow is called "ischemic heart disease".

coronary vessels clogged system plaques of atherosclerotic origin, which narrows the inner lumen. When administered intravenously Riboxinum solution state improves infarction patient in full screen.

It's important to know! Intravenous administration of drug is also recommended for therapeutic treatment of glaucoma, as well as liver and kidney.

Severe cardiovascular disease: Treatment Riboxinum (i.v.)

"Myocardial infarction" refers to a partial necrosis of the heart muscle at the cellular levelWhich occurs due to impaired coronary patency.

Timely provision of medical support helps patients to resume previous work of the heart. In place of necrosis is formed connective tissue scarring.

Attention! Riboksin in ampoules, after suffering a heart attack, helps rapid recovery, normalizing cell renewal (on the application of the recommendations later in the instructions).

Injured cells by necrosis located next to restored, it is a necessity for a full body work.

Riboxinum: instructions for use (ampoules)

During a heart attack Riboksin intravenously drop by. 2% drug ampoule (10 ml) was added in 0.9% sodium chloride (250 mL) or 5% glucose. The first disposable dropper is carried out taking 200 ml per day.

With good tolerability riboksina patient, the dose may be increased to 4 ampoules of 10 ml per day in two divided doses.

therapy does not have the same schema, on average it is 10 to 14 days. Next, a doctor's appointment may be as those to receive tablet formulation of the drug.

In some cases, the drug may be administered to a slow stream (at an attack arrhythmias).

Treatment Riboxinum other pathologically severe disease with exacerbations

During acute hepatitis Riboxinum treated solution by intravenous drip. In this variation implies such a scheme: drop speed - 50 units. 60 seconds.

This method allows you to quickly activate the liver, nourishing them with energy, increasing resistance to infections.

Severe chronic hepatitis B have a negative impact on the functionality of the body.

Intravenous administration riboksin in vials (use according to the instructions) shall drop by over 14 days, with a further transition to tableted therapy.

In severe pathological processes associated with renal blood supply (to provoke death of kidney tissue) also prescribes the introduction Riboxin.

This pathology is possible after surgery or organ injury.

The course of treatment is assigned individually doctor, Based on the characteristics of the disease and the condition of patients.

When you can not enter Riboksin intravenously

Intravenous administration is forbidden in the following cases:

• disease accompanied by pathological decrease renal functionality;
• pregnancy;
• Children and adolescents under 18 years of age;
• drug intolerance components;
• lactation;
• gout.

Most often, medical therapy was well tolerated, but in some cases the attacks of tachycardia. Then the doctor decide on the cancellation or reduction of the dosage of the drug.

In patients prone to allergic manifestations frequently reported adverse reactions.

Guide to the preparation Riboksin (iv)

Riboxinum: instructions for use in ampoules involves the use of the drug for intravenous administration, tablets - oral.

Structure

1 tablet contains:

• riboksin - 0.2 g;
• potato starch;
• calcium stearate;
• powdered sugar.

The structure of the following solution:

• inosine;
• hexamethylenetetramine;
• sodium hydroxide.

Indications

One of modern medicine, which has a positive effect on the metabolism and energy supply of the organism tissue, the drug is Riboxin.

Instructions for use (in capsules or tablets) provides for the use of funds in the following cases:

• surgery in isolated kidneys (pharmacological protection during flow switching);
• liver disease;
• complex therapy after myocardial;
• the broken heart;
• ischemia.

Drug tablets taken orally before meals.

Drug treatment has an individual reception circuit. The duration of treatment of 30 to 90 days.

Features

It takes control of uric acid levels in plasma.

The drug does not inhibits the attention and does not affect the traffic management capabilities.

Pregnancy and lactation

Instructions for use Riboxinum medicines (ampoules) indicates pregnancy and lactation as contraindications for treatment in these cases, but doctors admit some exceptions.

In pregnant women, due to increased heart load requires additional supporting, in particular, in cases of slow development of the fetus within the womb, as well as structural or functional violations.

It's important to know! Despite these contraindications for use during pregnancy and lactation, the drug can be administered by doctors in some cases.

Most often recommended for pregnant women taking the drug in tablets. The course of therapy and dose determined by the physician on an individual basis. For this purpose, it provided the extent and severity of pathologic symptoms. In rare cases, intravenous administration.

Breastfeeding is not a contraindication to receiving the drug, but at the time of treatment is better to transfer the baby to bottle-feeding.

The body of children is very sensitive, the penetration of the drug in the mother's milk can not cause the desired reaction.

Interactions with other drugs

Receiving funds from antianginal, inotropic, anti-arrhythmic agents increases their effectiveness.

When combined with cardiac glycosides group prevented the arrhythmia, increasing inotropic effects.

release Form

Tablets - rounded shape, the color of pale yellow, film coating is applied.

Solution - no color or weak staining.

Storage conditions

Recommendations for storage - a secure, dark place with a temperature mode 18-25 degrees, without the reach of children.

Validity - 24 months from that date on the package.

Conditions of supply in pharmacies and price

The price of the drug ranges from 38 to 62 rubles. Prescription. In the online pharmacy you can buy medicine without it.

analogs riboksin

Riboxinum replace drugs with similar activities and dosage of the active ingredients. In inosine and Ribozina similar pharmacology, application methods, dosage.

Drug selection is carried out on the basis of customer reviews, medical advice. Particular attention is required when selecting the analogue focusing on the impact mechanisms.

Drugs must meet all the same characteristics as the Riboksin: increase the energy supply at the cellular level, to accelerate metabolism.

inosine

The instructions to the drug indicated that it is a complete replacement for riboksin, Including in capsules. It is also a precursor of ATP, it renders both antihypoxia, metabolic, and an antiarrhythmic effect.

When applied improves performance infarction, coronary flow establishes, combats the effects of intraoperative renal ischemia.

Involved in glucose metabolism with hypoxia. There stimulation nucleotide synthesis, increasing enzyme production in the Krebs cycle.

After penetrating the cells increases the energy level, with a positive effect on the metabolism of the myocardium.

Ribonozin

The drug metabolic effect with antihypoxic, metabolic and antiarrhythmic action.

Increases the energy of the heart muscle, has a positive effect on the coronary blood flow, Struggling with the effects of intraoperative renal ischemia. Involved in glucose metabolism.

Due to activation of metabolism of pyruvic acid is provided by the normal process of oxygen delivery to cells.

mildronat

Mildronat - structural analogue meldonium (substance in human cells).

Recommended for reception when diagnosed vascular and degenerative fundus disease, functional disorders of the nervous system, ischemic disturbances of cerebral blood flow.

The drug restores the heart rate, reducing the risk of angina, Increases physical and mental performance, multiplies the energy supply in the cells.

Important! Mildronat - preparation of new generation with improved formula for the treatment of heart disease. Reviews of patients and doctors talk about high efficiency of medical therapy.

cytoflavin

Drug metabolic action, improves the cell supply. It activates enzymes antioxidants improves cellular respiration, removes free radicals, with a further decline of their formation.

Tsitoflovin improves cerebral blood flow and heart.

The drug is recommended for cerebral circulatory disorders, acute cardiac pathological processes during trophic, dyscirculatory, toxic encephalopathies.

It contributes to the improvement of metabolic processes at the cellular level and restores memory loss and attention, mental productivity.

Taking the drug after stroke (in the first 10 hours) contributes to a significant reduction in brain lesion focus, which reduces the risk of possible disability.

Despite the wide range of products replacing Riboksin, Only a specialist can make an appointment, to pick up the scheme of medical treatment.

To do this, take into account the diagnostic data and the general condition of the patient to the possible reactions of the organism.

In this video you will learn about the preparation Riboksin, instructions for its use in capsules and tablets:

This video introduces you to the basic information about Riboksin: